46106-1 Medical record number [Identifier]

Fully-Specified Name

Component

Medical record number

Property

ID

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

MRN

Basic Attributes

Class

ADMIN.PATIENT.ID

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.66

Change Reason

Removed method of MDS and copyright information since this is not an MDS-specific concept. Also change scale from narrative to nominal since this is not a narrative concept.; Changed CLASS from SURVEY.MDS to ADMIN

Order vs. Observation

Observation

HL7^® Attributes

HL7^® Field ID

PID-3

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• ADMIN.PATIENT.ID
• Ident
• Identifier
• Intradermal
• Medical record no.
• MRN
• No
• Nominal
• Num
• Point in time
• Random

Related Codes

45397-7 Medicare or comparable number

Fully-Specified Name

Component

Medicare or comparable number

Property

ID

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Medicare or comparable #

Basic Attributes

Class

ADMIN.PATIENT.ID

Type

Clinical

First Released

Version 2.17

Last Updated

Version 2.66

Change Reason

Changed CLASS to ADMIN

Order vs. Observation

Both

HL7^® Attributes

HL7^® Field ID

PID-3

Member of these Panels

Language Variants Get Info

Related Names

• ADMIN
• ADMIN.PATIENT
• ADMIN.PATIENT.ID
• Ident
• Identifier
• Intradermal
• Medicare or comparable #
• No
• Nominal
• Num
• Point in time
• Random

Related Codes

42071-1 Accession number and class of case and sequence number override flag Cancer case

Term Description

Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct.

This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software:
Accession Number, Class of Case, Seq Number (COC)... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC

Fully-Specified Name

Component

Accession number & class of case & sequence number override flag

Property

Arb

Time

Pt

System

Cancer case.XXX

Scale

Ord

Method

Additional Names

Short Name

Ascn/class/seq O/R Cancer case

Basic Attributes

Class

TUMRRGT

Type

Clinical

First Released

Version 2.16

Last Updated

Version 2.73

Common Test Rank Get Info

16584

Normative Answer List LL152-0

Member of these Panels

Language Variants Get Info

Related Names

• Arbitrary
• Ascn/class/seq O/R
• CA
• Misc
• Miscellaneous
• No
• Num
• Oncology
• Ordinal
• Other
• Point in time
• QL
• Qual
• Qualitative
• Random
• Screen
• Spec
• To be specified in another part of the message
• TUMOR REGISTRY(NAACCR)
• Unspecified

Related Codes

63907-0 Clinician-diagnosed illness [PhenX]

Fully-Specified Name

Component

Clinician-diagnosed illness

Property

Find

Time

Pt

System

^Patient

Scale

Nom

Method

PhenX

Additional Names

Short Name

Clinician-diagnosed illness PhenX

Basic Attributes

Class

PHENX

Type

Clinical

First Released

Version 2.36

Last Updated

Version 2.65

Change Reason

Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

Survey Question

Source

PX070801010000

Normative Answer List LL1116-4

Member of these Panels

Language Variants Get Info

Related Names

• Finding
• Findings
• Nominal
• Point in time
• Random

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

29306-8 Surgery procedure

Fully-Specified Name

Component

Surgery procedure

Property

Type

Time

Pt

System

^Patient

Scale

Nom

Method

Additional Names

Short Name

Surgery procedure

Basic Attributes

Class

H&P.PX

Type

Clinical

First Released

Version 2.03

Last Updated

Version 2.29

Member of these Panels

Language Variants Get Info

Related Names

• H+P
• H+P.PX
• Nominal
• P prime
• Point in time
• Random
• Surg
• Typ

Related Codes

2857-1 Prostate specific Ag [Mass/volume] in Serum or Plasma

Part Descriptions

LP18193-0   Prostate specific Ag
Prostate-specific antigen is a glycoprotein and occurs in three forms in the blood: 1) PSA complexed with the serine protease inhibitor or alpha-1-antichymotrypsin, 2) free or uncomplexed PSA, and 3) PSA complexed with alpha-2 macroglobulin. The first two are detectable and the third is undectectable in conventional immunoassay. Elevated levels of PSA in serum or plasma indicate a pathological condition of the prostate (e.g. carcinoma, benign prostatic hyperplasia (BPH), or prostatitis). Inflammation or trauma to the prostate, such as following a biopsy or colonoscopy, can result in PSA elevations. PSA levels are also checked to monitor therapy in patients with prostate cancer. Source: Regenstrief LOINC

Fully-Specified Name

Component

Prostate specific Ag

Property

MCnc

Time

Pt

System

Ser/Plas

Scale

Qn

Method

Additional Names

Short Name

PSA SerPl-mCnc

Display Name

Prostate specific Ag [Mass/Vol]

Consumer Name Alpha Get Info

Prostate specific antigen, Blood

Basic Attributes

Class

CHEM

Type

Laboratory

First Released

Version 1.0

Last Updated

Version 2.73

Order vs. Observation

Both

Common Test Rank Get Info

177

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

• Antigen
• Antigens
• Chemistry
• Genitourinary
• GU
• Kallikrein 3
• Level
• Mass concentration
• Oncology
• P-30 antigen
• Pl
• Plasma
• Plsm
• Point in time
• PS
• PSA
• QNT
• Quan
• Quant
• Quantitative
• Random
• Seminin
• SerP
• SerPl
• SerPlas
• Serum
• Serum or plasma
• Spec
• SR
• Tumor marker
• UniversalLabOrders
• URO
• Urology

Example Units

55752-0 Clinical information

Term Description

A section containing clinical details about the case such as presenting signs and symptoms, onset date of symptoms, the specific diagnosis/condition names (e.g Ulceroglandular tularemia), who made the diagnosis, their contact information , when the diagnosis was made etc., past clinical hx, the overall condition of the patient, etc.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Clinical information

Property

Find

Time

Pt

System

^Patient

Scale

Nar

Method

Additional Names

Short Name

Clinical info

Basic Attributes

Class

PUBLICHEALTH

Type

Clinical

First Released

Version 2.27

Last Updated

Version 2.73

Common Test Rank Get Info

1702

Member of these Panels

Language Variants Get Info

Related Names

• AOEObservation
• Finding
• Findings
• Narrative
• Point in time
• Public Health
• PUBLICHEALTH
• Random
• Report

21908-9 Stage group.clinical Cancer

Term Description

Detailed site-specific codes for the clinical stage group as defined by AJCC and recorded by the physician. Pathologic, clinical, and other stage data are given three separate areas in the NAACCR Data Exchange Record Layout.

COC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results... NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC

Fully-Specified Name

Component

Stage group.clinical

Property

Class

Time

Pt

System

Cancer.XXX

Scale

Nom

Method

Additional Names

Short Name

Stg grp.clinical Cancer

Basic Attributes

Class

TUMRRGT

Type

Clinical

First Released

Version 1.0m

Last Updated

Version 2.32

Normative Answer List LL240-3

Member of these Panels

Language Variants Get Info

Related Names

• CA
• Misc
• Miscellaneous
• Nominal
• Oncology
• Other
• Point in time
• Random
• Spec
• Stg grp.clinical
• To be specified in another part of the message
• TUMOR REGISTRY(NAACCR)
• Unspecified

Related Codes

33723-8 Specimen length

Fully-Specified Name

Component

Specimen length

Property

Len

Time

Pt

System

Specimen

Scale

Qn

Method

Additional Names

Short Name

Specimen length

Display Name

Specimen length (Spec) [Length]

Consumer Name Alpha Get Info

Specimen length, Specimen

Basic Attributes

Class

PATH.PROTOCOLS.GENER

Type

Laboratory

First Released

Version 2.09

Last Updated

Version 2.70

Change Reason

Removed Method since this term is not specific to CAP cancer protocols.

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Len
• Length
• Pathology
• PATHOLOGY PROTOCOLS
• PATHOLOGY PROTOCOLS general
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Spec

Example Units

84894-5 Dimension [Length] of Specimen

Term Description

The size of a specimen may be recorded in two or more linear measurements (dimensions), e.g. length and width. Each dimension can be recorded by repeating this term. Specimen dimensions enable comparison with clinical and imaging estimates of volume. To record only the length of a specimen, use "Specimen length" [LOINC: 33723-8]. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Dimension

Property

Len

Time

Pt

System

Specimen

Scale

Qn

Method

Additional Names

Short Name

Dimension Spec

Display Name

Dimension (Spec) [Length]

Consumer Name Alpha Get Info

Dimension, Specimen

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.68

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Length
• Pathology
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Spec

Example Units

84895-2 Seminal vesicles [Presence] in Specimen

Term Description

The presence (partially or completely resected) or absence of seminal vesicles in the specimen. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Seminal vesicles

Property

PrThr

Time

Pt

System

Specimen

Scale

Ord

Method

Additional Names

Short Name

Seminal vesicles Spec Ql

Display Name

Seminal vesicles Ql (Spec)

Consumer Name Alpha Get Info

Seminal vesicles, Specimen

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL3950-4

Member of these Panels

Language Variants Get Info

Related Names

• Ordinal
• PATHOLOGY
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• Screen
• Spec

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

84896-0 Lymph node(s) [Presence] in Specimen

Term Description

The presence or absence of lymph nodes in the specimen. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Lymph node(s)

Property

PrThr

Time

Pt

System

Specimen

Scale

Ord

Method

Additional Names

Short Name

Lymph node(s) Spec Ql

Display Name

Lymph node(s) Ql (Spec)

Consumer Name Alpha Get Info

Lymph node(s), Specimen

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL3950-4

Member of these Panels

Language Variants Get Info

Related Names

• LN
• Ordinal
• Pathology
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• S prime
• Screen
• Spec

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

84897-8 Dominant nodule quadrant [Anatomy] in Prostate tumor

Term Description

The quadrant (e.g. right anterior, right posterior, left anterior or left posterior) in which the dominant (largest) nodule of the tumor is located. To record the quadrant in which the other nodule(s) are located, use [LOINC: 84900-0]. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Dominant nodule quadrant

Property

Anat

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Dominant nodule quad PrT

Display Name

Dominant nodule quadrant Nom (Prostate tumor)

Consumer Name Alpha Get Info

Dominant nodule quadrant, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4079-1

Member of these Panels

Language Variants Get Info

Related Names

• Anatomy
• Cancer
• Nominal
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours

84898-6 Dominant nodule plane [Anatomy] in Prostate tumor

Term Description

The location of the dominant (largest) nodule by plane (e.g. apex, mid, or base of prostate). This information is important for correlation with needle biopsy findings, imaging results, etc. To record the location of other nodule(s) by plane, use [LOINC: 84901-8]. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Dominant nodule plane

Property

Anat

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Dominant nodule plane PrT

Display Name

Dominant nodule plane Nom (Prostate tumor)

Consumer Name Alpha Get Info

Dominant nodule plane, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4080-9

Member of these Panels

Language Variants Get Info

Related Names

• Anatomy
• Cancer
• Nominal
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours

84899-4 Other nodules greater than 10mm in diameter [Presence] in Prostate tumor

Term Description

The presence or absence of other nodules greater than 10 mm in diameter in addition to the dominant (largest) nodule in the prostate tumor. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Other nodules greater than 10mm in diameter

Property

PrThr

Time

Pt

System

Prostate tumor

Scale

Ord

Method

Additional Names

Short Name

Other nodules >10mm diameter PrT Ql

Display Name

Other nodules greater than 10mm in diameter Ql (Prostate tumor)

Consumer Name Alpha Get Info

Other nodules greater than 10mm in diameter, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL3950-4

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• DIA
• Diam
• Ordinal
• Other nodules &gt
• 10mm diameter
• Othr
• Pathology
• Point in time
• PR
• Prost
• Prostatic
• QL
• Qual
• Qualitative
• Random
• Screen
• tumors
• tumour
• tumours

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

84900-0 Other nodule quadrant [Anatomy] in Prostate tumor

Term Description

The quadrant (e.g. right anterior, right posterior, left anterior or left posterior) in which the other nodule(s) are located. To record the quadrant location of the dominant (largest) nodule, use [LOINC: 84897-8]. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Other nodule quadrant

Property

Anat

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Nodule quad PrT

Display Name

Other nodule quadrant Nom (Prostate tumor)

Consumer Name Alpha Get Info

Other nodule quadrant, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4079-1

Member of these Panels

Language Variants Get Info

Related Names

• Anatomy
• Cancer
• Nominal
• Othr
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours

84901-8 Other nodule plane [Anatomy] in Prostate tumor

Term Description

The location of the other nodule(s) by plane (e.g. apex, mid, or base of prostate). To record the plane location of the dominant (largest) nodule, use [LOINC: 84898-6]. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Other nodule plane

Property

Anat

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Other nodule plane PrT

Display Name

Other nodule plane Nom (Prostate tumor)

Consumer Name Alpha Get Info

Other nodule plane, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4080-9

Member of these Panels

Language Variants Get Info

Related Names

• Anatomy
• Cancer
• Nominal
• Othr
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours

44657-5 Dominant nodule.maximum.dimension in Prostate tumor

Fully-Specified Name

Component

Dominant nodule.max.dimension

Property

Len

Time

Pt

System

Prostate tumor

Scale

Qn

Method

Additional Names

Short Name

Dom nodule.max.dim PrT

Display Name

Dominant nodule.maximum.dimension (Prostate tumor) [Length]

Consumer Name Alpha Get Info

Dominant nodule.maximum.dimension, Prostate Tumor

Basic Attributes

Class

PATH.PROTOCOLS.PROST

Type

Laboratory

First Released

Version 2.17

Last Updated

Version 2.70

Change Reason

Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols.

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• Dom nodule.max.dim
• Largest
• Length
• Maximal
• Maximum
• Pathology
• PATHOLOGY PROTOCOLS
• PATHOLOGY PROTOCOLS PROSTATE
• Peak
• Point in time
• Prost
• Prostatic
• PrT
• QNT
• Quan
• Quant
• Quantitative
• Random
• tumors
• tumour
• tumours

Example Units

44654-2 Tissue involved by tumor in Prostate tumor

Fully-Specified Name

Component

Prostatic tissue involved by tumor

Property

NFr

Time

Pt

System

Prostate tumor

Scale

Qn

Method

Additional Names

Short Name

Tissue involved by tumor PrT

Display Name

Tissue involved by tumor (Prostate tumor)

Consumer Name Alpha Get Info

Tissue involved by tumor, Prostate Tumor

Basic Attributes

Class

PATH.PROTOCOLS.PROST

Type

Laboratory

First Released

Version 2.17

Last Updated

Version 2.58

Change Reason

Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols.

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• Intraglandular extent
• Number fraction
• PATHOLOGY
• PATHOLOGY PROTOCOLS
• PATHOLOGY PROTOCOLS PROSTATE
• Percent
• Point in time
• Prost
• Prostate
• Prostati
• Prostatic
• PrT
• QNT
• Quan
• Quant
• Quantitative
• Random
• tumors
• tumour
• tumours

Example Units

35266-6 Gleason score in Specimen Qualitative

Fully-Specified Name

Component

Gleason score

Property

Score

Time

Pt

System

Specimen

Scale

Ord

Method

Additional Names

Short Name

Gleason Score Spec Ql

Display Name

Gleason score Ql (Spec)

Consumer Name Alpha Get Info

Gleason score, Specimen

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.12

Last Updated

Version 2.50

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• GS
• Ordinal
• PATHOLOGY
• Point in time
• QL
• Qual
• Qualitative
• Random
• Scale
• Screen
• Spec

Example Units

84903-4 Extraprostatic extension extent [Type] of Prostate tumor

Term Description

Categorization of the extent of extraprostatic extension (EPE) as focal or non-focal (also called established or extensive). The identification of any EPE is important since both focal and non-focal EPE are associated with a significantly higher risk of recurrence. PMID: 9712429 This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Extraprostatic extension extent

Property

Type

Time

Pt

System

Prostate tumor

Scale

Ord

Method

Additional Names

Short Name

EPE extent PrT Ql

Display Name

Extraprostatic extension extent Ql (Prostate tumor)

Consumer Name Alpha Get Info

Extraprostatic extension extent, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL4082-5

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• EPE extent
• EXT
• Ordinal
• PATHOLOGY
• Point in time
• Prost
• Prostatic
• PrT
• Ql
• Qual
• Qualitative
• Random
• Screen
• tumors
• tumour
• tumours
• Typ

84902-6 Extraprostatic extension site [Anatomy] of Prostate tumor

Term Description

The location of extraprostatic extension (EPE), if present. EPE is defined as the extension of tumor beyond the confines of the gland into the periprostatic soft tissue. The locations include apical, bladder neck, anterior, lateral, postero-lateral, and posterior. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Extraprostatic extension site

Property

Anat

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Extraprostatic ext site PrT

Display Name

Extraprostatic extension site Nom (Prostate tumor)

Consumer Name Alpha Get Info

Extraprostatic extension site, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4081-7

Member of these Panels

Language Variants Get Info

Related Names

• Anatomy
• Cancer
• EXT
• Extraprostatic ext site
• Nominal
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours

81168-7 Site of adjacent organ or tissue involvement Cancer specimen

Term Description

Tumor stages are based on the extent of the involvement of adjacent tissues or organs, such as skin, liver, spleen, or pancreas as well as distal spread (i.e., metastasis). This term is used to report which adjacent tissue or organ(s) the tumor has spread to from the primary organ involved.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Site of adjacent organ or tissue involvement

Property

Anat

Time

Pt

System

Cancer specimen

Scale

Nom

Method

Additional Names

Short Name

Adj org or tiss involved Ca spec

Basic Attributes

Class

CLIN

Type

Clinical

First Released

Version 2.56

Last Updated

Version 2.61

Change Reason

Changed System from "Stomach cancer" to "Cancer.XXX" since this observation can be used for various cancers.; Updated System from "Cancer.XXX" to clarify that the test is performed on a cancer specimen.

Order vs. Observation

Observation

Example Answer List LL3943-9

Member of these Panels

Language Variants Get Info

Related Names

• Adj org or tiss involved
• Anatomy
• CA
• Ca spec
• CLIN
• Nominal
• Point in time
• Random
• Spec

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

44654-2 Tissue involved by tumor in Prostate tumor

Fully-Specified Name

Component

Prostatic tissue involved by tumor

Property

NFr

Time

Pt

System

Prostate tumor

Scale

Qn

Method

Additional Names

Short Name

Tissue involved by tumor PrT

Display Name

Tissue involved by tumor (Prostate tumor)

Consumer Name Alpha Get Info

Tissue involved by tumor, Prostate Tumor

Basic Attributes

Class

PATH.PROTOCOLS.PROST

Type

Laboratory

First Released

Version 2.17

Last Updated

Version 2.58

Change Reason

Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols.

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• Intraglandular extent
• Number fraction
• PATHOLOGY
• PATHOLOGY PROTOCOLS
• PATHOLOGY PROTOCOLS PROSTATE
• Percent
• Point in time
• Prost
• Prostate
• Prostati
• Prostatic
• PrT
• QNT
• Quan
• Quant
• Quantitative
• Random
• tumors
• tumour
• tumours

Example Units

84904-2 Gleason score at positive margin in Prostate tumor Qualitative

Term Description

The Gleason score of the tumor at the positive surgical margin (PSM) is a recommended element of the International Collaboration on Cancer Reporting (ICCR) dataset.(http://www.iccr-cancer.org/datasets) If there are multiple PSMs with differently scored cancers present, the highest score is recorded. The Gleason score at the PSM is a known independent predictor of biochemical recurrence and may be used in the selection of patients for adjuvant therapy. PMID: 21992536 This term was created for, but not limited in use to, the cancer structured reporting protocols developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of various cancers.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Gleason score at positive margin

Property

Score

Time

Pt

System

Prostate tumor

Scale

Ord

Method

Additional Names

Short Name

Gleason score at pos margin PrT Ql

Display Name

Gleason score at positive margin Ql (Prostate tumor)

Consumer Name Alpha Get Info

Gleason score at positive margin, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL746-9

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• Gleason score at pos margin
• GS
• Ordinal
• PATHOLOGY
• Point in time
• Pos
• Prost
• Prostatic
• PrT
• Ql
• Qual
• Qualitative
• Random
• Scale
• Screen
• tumors
• tumour
• tumours

84905-9 Margin involvement [Type] in Prostate tumor

Term Description

The type of positive margin involvement in prostate tumor is either extraprostatic extension (EPE) or intraprostatic (capsular incision). Margin involvement associated with EPE is diagnosed when malignant glands in extraprostatic tissue are transected by the resection margin. Intraprostatic margin involvement occurs when the urologist inadvertently develops the resection margin within the plane of the prostate rather than outside the capsule. Intraprostatic with a positive surgical margin is diagnosed when malignant glands are cut across adjacent to benign prostatic glands. In these cases, the edge of the prostate in this region is left in the patient. According to the largest series published, a significantly higher recurrence rate is found in patients with CI/intraprostatic margin involvement than in patients with organ confined disease with negative margins, or focal EPE with negative margins, although CI has a significantly better outcome than that associated with non-focal EPE and positive margins. PMID: 17698141 This term was created for, but not limited in use to, the Royal College of Pathologists of Australasia (RCPA) Prostate cancer structured reporting protocol, 2nd edition (2014).
Source: Regenstrief LOINC

Fully-Specified Name

Component

Margin involvement

Property

Type

Time

Pt

System

Prostate tumor

Scale

Nom

Method

Additional Names

Short Name

Margin involved PrT

Display Name

Margin involvement Nom (Prostate tumor)

Consumer Name Alpha Get Info

Margin involvement, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Preferred Answer List LL4083-3

Member of these Panels

Language Variants Get Info

Related Names

• Cancer
• Margin involved
• Nominal
• Pathology
• Point in time
• Prost
• Prostatic
• PrT
• Random
• tumors
• tumour
• tumours
• Typ

84895-2 Seminal vesicles [Presence] in Specimen

Term Description

The presence (partially or completely resected) or absence of seminal vesicles in the specimen. This term was created for, but not limited in use to, the Prostate Cancer (Radical Prostatectomy) Structured Reporting Protocol (2nd Edition, 2014) developed by the Royal College of Pathologists of Australasia (RCPA) for structured reporting of prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Seminal vesicles

Property

PrThr

Time

Pt

System

Specimen

Scale

Ord

Method

Additional Names

Short Name

Seminal vesicles Spec Ql

Display Name

Seminal vesicles Ql (Spec)

Consumer Name Alpha Get Info

Seminal vesicles, Specimen

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL3950-4

Member of these Panels

Language Variants Get Info

Related Names

• Ordinal
• PATHOLOGY
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• Screen
• Spec

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

84906-7 Bladder neck involvement of Prostate tumor

Term Description

This term is used to record whether or not the urinary bladder neck is involved with the prostate tumor. Microscopically, invasion of the bladder neck can be identified when there are neoplastic glands within the thick smooth muscle bundles of the bladder neck in sections from the base of the prostate in the absence of associated benign prostatic glandular tissue.
Source: Regenstrief LOINC

Fully-Specified Name

Component

Bladder neck involvement

Property

PrThr

Time

Pt

System

Prostate tumor

Scale

Ord

Method

Additional Names

Short Name

Bladder neck involved PrT Ql

Display Name

Bladder neck involvement Ql (Prostate tumor)

Consumer Name Alpha Get Info

Bladder neck involvement, Prostate Tumor

Basic Attributes

Class

PATH

Type

Laboratory

First Released

Version 2.58

Last Updated

Version 2.71

Order vs. Observation

Observation

Example Answer List LL4076-7

Member of these Panels

Language Variants Get Info

Related Names

• Bladder neck involved
• Cancer
• Ordinal
• PATHOLOGY
• Point in time
• PR
• Prost
• Prostatic
• QL
• Qual
• Qualitative
• Random
• Screen
• tumors
• tumour
• tumours